Hyaluronidase Boosts Antibody Delivery in HIV Prevention Trial
A groundbreaking phase 1 clinical trial has demonstrated a promising advancement in the subcutaneous delivery of broadly neutralizing antibodies (bNAbs) ...
A groundbreaking phase 1 clinical trial has demonstrated a promising advancement in the subcutaneous delivery of broadly neutralizing antibodies (bNAbs) ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine